The library consists of iABC related publications, posters, presentations, and press releases
|Poster ERS 2018
Multiple Breath Washout (MBW) training, certification and quality control during the iBEST 1 trial in bronchiectasis (BE).
|The EMBARC European Bronchiectasis Registry Protocol
Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no approved therapies and few large-scale, representative epidemiological studies.
|Cross-infection risk in patients with bronchiectasis
a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network
|Patient participation in ERS guidelines and research projects
The EMBARC experience
|iBest 1 poster (2017)
Dose-finding study to assess the efficacy, safety and tolerability of tobramycin inhalation powder in patients with non-cystic fibrosis bronchiectasis and pulmonary Pseudomonas aeruginosa infection (iBEST-1)
|Use of Calgary and microfluidic BioFlux systems
To test the activity of fosfomycin and tobramycin alone and in combination against cystic fibrosis Pseudomonas
|Design of the iBest study
Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1)